Drug profile · INN
iodoxamate meglumine
CHOLOVUE
iodoxamate meglumine (CHOLOVUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Drug details — iodoxamate meglumine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
iodoxamate meglumine (CHOLOVUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is iodoxamate meglumine?
iodoxamate meglumine (CHOLOVUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for iodoxamate meglumine?
CHOLOVUE is a marketed brand name for iodoxamate meglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of iodoxamate meglumine?
iodoxamate meglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.